TNF and inflammatory bowel disease: The difficult task of unraveling the complex interactions implicated in the response to anti-TNFα therapy in patients with PsO, IBD, and RA, as well as distinguishing gene clusters and pathways that are altered by this heterogeneous phenotype, could be aided by meta-analysis of such gene expression data.